NCT00976794 Efficacy of Combined Treatment for Young Bipolar I Disorder Status COMPLETED Phase PHASE4
NCT00958633 Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder. Status TERMINATED Phase PHASE3
NCT00857818 Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome Status TERMINATED Phase PHASE3
NCT00746343 Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study Status COMPLETED Phase NA
NCT00721955 Staccato Loxapine in Agitated Patients With Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00709202 Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain Status COMPLETED Phase PHASE2
NCT00618748 Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed Status COMPLETED Phase PHASE3
NCT00608075 Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder Status UNKNOWN Phase PHASE4
NCT00606320 A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Status COMPLETED Phase PHASE3
NCT00606281 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Status COMPLETED Phase PHASE3
NCT00606229 A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Status COMPLETED Phase PHASE3
NCT00606177 A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Status COMPLETED Phase PHASE3
NCT00402324 A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients Status COMPLETED Phase PHASE4
NCT00238485 An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00232414 A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00228059 An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder. Status COMPLETED Phase PHASE3
NCT00227305 Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents Status COMPLETED Phase PHASE3